Filter
48
Filtered Results: 48
Text search:
immunity
passport
Featured
Recommendations
10
New Publications
9
Language
Document type
No document type
17
Guidelines
12
Fact sheets
7
Studies & Reports
6
Manuals
5
Situation Updates
1
Countries / Regions
Global
3
East and Southern Africa
3
Namibia
3
Africa
2
Germany
2
West and Central Africa
2
Vietnam
2
India
2
Myanmar / Burma
2
Thailand
1
Lesotho
1
Ghana
1
Laos
1
Malawi
1
Cambodia
1
Latin America and the Carribbean
1
South–East Asia Region
1
Western Pacific Region
1
Western and Central Europe
1
France
1
Bangladesh
1
Eastern Europe
1
Brazil
1
South Sudan
1
Authors & Publishers
Publication Years
Category
COVID-19
7
Virology
3
Studies & Reports
3
Policies & Guidelines HIV & TB
2
Guidelines
2
Capacity Building
2
Humanitarian Crisis
2
Communicable Diseases
1
Clinical Training
1
Child Health
1
Palliative Care
1
Child protection
1
Policies
1
Drugs & Medical Equipment
1
Women & Child Health
1
Community Health
1
Palliative Care
1
Immunization
1
Toolboxes
Context & Facts, Travel Advice
9
Country specific documents
6
Diagnostics & Laboratory Guidance
5
Human Rights
5
Surveillance & Contact tracing
4
Human Rights
2
Clinical Guidelines
2
Prevention & Preparedness
2
COVID-19 Vaccination
2
Disability Rights & Convention
1
Vaccines & Immunization
1
Vaccination
1
International
1
South Sudan
1
Policies
1
General Mental Health Guidelines
1
TB & Other Vulnerable Populations
1
Discrimination & Stigma
1
Medical professionals
1
Clinical Aspects
1
Infection Control General
1
For Migrants & Refugees
1
Global Impact: Socio-economic, health services, TB & HIV
1
Child Protection
1
Scientific & Research Studies
1
RCCE Guides & Manuals
1
Access & Strategy
1
Fair Allocation & Ethical Aspects
1
COVID-19 Vaccination Information
1
Advocacy & Communication
1
General Information & Methodology
1
Children's Rights
1
Asia and Pacific
1
Disease Prevention & Control
1
HIV in Key Populations
1
Situation Reports & Updates
1
Reports & Studies
1
Eastern Europe and central Asia
1
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
The following protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 virus infection has been reported. Each country may need to tailor some aspects of this protocol to align with public health, l...
La 3ieme édition du nouveau mini-manuel.
Au cours des mois à venir COVID Reference publiera des mises à jour régulières.
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera...
Document d’information scientifique
24 avril 2020
Le développement d’une immunité face à un agent pathogène à la suite d’une infection naturelle comporte plusieurs étapes et prend généralement une à deux semaines. Une infection virale entraîne immédiatement une réponse immunit...
- Interim guide: May 2020 update.
On the 25th of March, the GPEI circulated the first update of the interim guide to help ensure continuity of the programme’s operations in the context of the COVID-19 pandemic, as well as its support to the pandemic response while also ensuring the safety of its ...
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information from trustworthy sources. Information is presented in...
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...
Tại nhiều quốc gia, cú sốc của làn sóng kiểm dịch thứ nhất đã lắng xuống, số ca bệnh cũng đã giảm, việc gỡ bỏ các lệnh phong tỏa đang được xem xét hoặc đã được thực hiện ở nhiều nơi. Vũ Hán đã mở cửa trở lại. Nhưng ph...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Updated 28 December 2020
This checklist helps to identify the necessary measures to be implemented to mitigate infection transmission among travellers and ground-crossing staff in the context of the COVID-19 pandemic. It features key questions and considerations for gauging the capacity of responding to COVID-19 transmissio...
Information sheet about coronavirus vaccination
recommended
Die Johanniter haben im Rahmen ihrer Aktivitäten im Bereich Flüchtlingshilfe und Integration allgemeine, niedrigschwellige Informationen zum Thema Corona-Impfung in verschiedenen Sprachen bereitgestellt. Diese dienen als Ergänzung zu den offiziellen Informationsmaterialien der Bundeszentrale für...
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
This is a guidance document for countries and implementing partners on the technical requirements for developing digital information systems for issuing standards-based interoperable digital certificates for COVID-19 vaccination status, and considerations for implementation of such systems, for the ...
Natural immunity against COVID-19
Scientific report 10 May 2021
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si...
